Page last updated: 2024-08-25

narciclasine and Lymphoma, Primary Effusion

narciclasine has been researched along with Lymphoma, Primary Effusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chaudhary, PM; Choi, S; Gopalakrishnan, R; Matta, H	1

Other Studies

1 other study(ies) available for narciclasine and Lymphoma, Primary Effusion

Article	Year
Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma. Scientific reports, 2020, 03-31, Volume: 10, Issue:1 Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Lymphoma, Primary Effusion; Mice; Phenanthridines; Plant Extracts; Xenograft Model Antitumor Assays	2020

Article

Year

Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma.

Scientific reports, 2020, 03-31, Volume: 10, Issue:1

Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Body Weight; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Lymphoma, Primary Effusion; Mice; Phenanthridines; Plant Extracts; Xenograft Model Antitumor Assays

2020